Ralf Altmeyer

{{short description|German virologist}}

{{Use dmy dates|date=July 2022}}

{{Infobox scientist

|name = Ralf Altmeyer

|image =

|alt =

|caption =

|birth_date = {{birth date and age|1966|7|8|df=y}}

|birth_place = Saarlouis, Germany

|citizenship =

|nationality = File:Flag of Germany.svg German

|ethnicity =

|death_date =

|death_place =

|fields = virology, influenza, SARS, infectious diseases, HIV, microbiology

|workplaces = [http://english.shanghaipasteur.cas.cn Institut Pasteur of Shanghai]
Griffith University of Australia

|alma_mater = State University of New York at Stony Brook
Institut Pasteur, Paris
University of Tübingen

|doctoral_advisor =

|doctoral_students =

|notable_students =

|known_for =

|author_abbrev_bot =

|author_abbrev_zoo =

|awards =

|religion =

|signature =

|signature_alt =

}}

Ralf M. Altmeyer is a German virologist who leads the Institut Pasteur of Shanghai,Official press release on the Chinese Academy of Sciences website - Feb 1, 2010 {{cite web |url=http://english.cas.cn/Ne/ICN/201002/t20100201_50594.shtml |title=IPS Appoints New Director General---Chinese Academy of Sciences |accessdate=2010-02-09 |url-status=dead |archiveurl=https://web.archive.org/web/20110716031400/http://english.cas.cn/Ne/ICN/201002/t20100201_50594.shtml |archivedate=2011-07-16 }} a joint institute of the Chinese Academy of Sciences, Institut Pasteur and Shanghai Municipal Government, founded in 2004.

He completed his pre-doctoral studies at the State University of New York at Stony Brook, and holds a Ph. D. (1994) from Institut Pasteur in Paris, where he also completed his postdoctoral thesis on neuropathogenesis of HIV infections (1996).{{fact|date=July 2022}}

His research interests including respiratory diseases, Hepatitis C, HIV, and focus on anti-infective therapeutic strategies.{{fact|date=July 2022}}

During his career of fifteen years at Institut Pasteur and the Pasteur international network, Ralf Altmeyer held various management positions including the position of CEO of the HKU-Pasteur Research Centre in Hong Kong. From 2003 to 2006 Ralf Altmeyer was the architect of a successful restructuring and establishment of the organization's new strategy.[http://www.hkupasteur.hku.hk/hkuip/aboutus_news.htm Official statement on the HKU-PRC Research Centre - July 2006] {{webarchive|url=https://web.archive.org/web/20090927192244/http://www.hkupasteur.hku.hk/hkuip/aboutus_news.htm |date=2009-09-27 }}

He left Institut Pasteur in 2006 to become the President of CombinatoRx-Singapore,[http://www.terrapinn.com/2008/bioinvest/C3375.stm Speaker list of the BioInvest Asia 2008 Forum] the infectious disease subsidiary of CombinatoRx (NASDAQ:CRXX), established in 2005 in collaboration with Bio*One Capital in Singapore. Ralf Altmeyer left CombinatoRx-Singapore in summer 2009 subsequent to the acquisition of the company by Forma Therapeutics. In 2011, he founded Advance BioChina, a Shanghai-based incubator company that helps global biotech companies access the Chinese market.

Ralf Altmeyer also holds the position of adjunct professor at Griffith University of Australia, Institute of Glycomics.[http://www.griffith.edu.au/science/institute-glycomics/staff List of staff at Institute of Glycomics of Griffith University] {{webarchive|url=https://web.archive.org/web/20091004070417/http://www.griffith.edu.au/science/institute-glycomics/staff |date=2009-10-04 }}